Diabetes causes the accelerated loss of cartilage during fracture repair which is reversed by insulin treatment.

[1]  L. McCabe.  Understanding the pathology and mechanisms of type I diabetic bone loss , 2007, Journal of cellular biochemistry.

[2]  Lorenz C Hofbauer,et al.  Osteoporosis in Patients With Diabetes Mellitus , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  D. Graves,et al.  Diminished Bone Formation During Diabetic Fracture Healing is Related to the Premature Resorption of Cartilage Associated With Increased Osteoclast Activity , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[4]  L. McCabe,et al.  Normal bone density obtained in the absence of insulin receptor expression in bone. , 2006, Endocrinology.

[5]  K. Jepsen,et al.  Three-dimensional Reconstruction of Fracture Callus Morphogenesis , 2006, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[6]  Eunice R. Lee.  Proteolytic enzymes in skeletal development: histochemical methods adapted to the study of matrix lysis during the transformation of a "cartilage model" into bone. , 2006, Frontiers in bioscience : a journal and virtual library.

[7]  Geert Carmeliet,et al.  Placental growth factor mediates mesenchymal cell development, cartilage turnover, and bone remodeling during fracture repair. , 2006, The Journal of clinical investigation.

[8]  Sheldon S. Lin,et al.  The effects of local insulin delivery on diabetic fracture healing. , 2005, Bone.

[9]  J. Aronson,et al.  Bone formation is impaired in a model of type 1 diabetes. , 2005, Diabetes.

[10]  T. Einhorn,et al.  Application of Histomorphometric Methods to the Study of Bone Repair , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  P. Vestergaard,et al.  Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk , 2005, Diabetologia.

[12]  Y. Seino,et al.  Osteoclastic function is accelerated in male patients with type 2 diabetes mellitus: the preventive role of osteoclastogenesis inhibitory factor/osteoprotegerin (OCIF/OPG) on the decrease of bone mineral density. , 2005, Diabetes research and clinical practice.

[13]  E. Krall,et al.  Inflammation is More Persistent in Type 1 Diabetic Mice , 2005, Journal of dental research.

[14]  I. Klöting,et al.  Histomorphometric evaluation of the influence of the diabetic metabolic state on bone defect healing depending on the defect size in spontaneously diabetic BB/OK rats. , 2004, Bone.

[15]  S. Apte.  A disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motifs: the ADAMTS family. , 2004, The international journal of biochemistry & cell biology.

[16]  I. Klöting,et al.  Improving Metabolic Control Reverses the Histomorphometric and Biomechanical Abnormalities of an Experimentally Induced Bone Defect in Spontaneously Diabetic Rats , 2004, Calcified Tissue International.

[17]  D. Graves,et al.  Impaired Fracture Healing in the Absence of TNF‐α Signaling: The Role of TNF‐α in Endochondral Cartilage Resorption , 2003 .

[18]  Sheldon S. Lin,et al.  Decreased Platelet Derived Growth Factor Expression During Fracture Healing in Diabetic Animals , 2003, Clinical orthopaedics and related research.

[19]  Sheldon S. Lin,et al.  The effects of blood glucose control upon fracture healing in the BB Wistar rat with diabetes mellitus , 2002, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[20]  D. Graves,et al.  Contribution of Interleukin-11 and Prostaglandin(s) in Lipopolysaccharide-Induced Bone Resorption In Vivo , 2002, Infection and Immunity.

[21]  A. Folsom,et al.  Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. , 2001, Diabetes care.

[22]  R. Cumming,et al.  Diabetes and risk of fracture: The Blue Mountains Eye Study. , 2001, Diabetes care.

[23]  T A Einhorn,et al.  Expression of Osteoprotegerin, Receptor Activator of NF‐κB Ligand (Osteoprotegerin Ligand) and Related Proinflammatory Cytokines During Fracture Healing , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[24]  A. Jirkovska,et al.  Calcaneal ultrasonometry in patients with Charcot osteoarthropathy and its relationship with densitometry in the lumbar spine and femoral neck and with markers of bone turnover , 2001, Diabetic medicine : a journal of the British Diabetic Association.

[25]  J. Lutterman,et al.  Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology , 2000, Journal of endocrinological investigation.

[26]  J. E. Hale,et al.  Alterations of Cartilage and Collagen Expression during Fracture Healing in Experimental Diabetes , 2000, Connective tissue research.

[27]  T A Einhorn,et al.  Growth Factor Regulation of Fracture Repair , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[28]  T. Rönnemaa,et al.  Bone mineral density in patients with type 1 and type 2 diabetes. , 1999, Diabetes care.

[29]  R. Wynn,et al.  Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. , 1999, Science.

[30]  S. Mohan,et al.  Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients. , 1998, The Journal of endocrinology.

[31]  T. Einhorn,et al.  Programmed removal of chondrocytes during endochondral fracture healing , 1998, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[32]  A. Gough,et al.  Measurement of Markers of Osteoclast and Osteoblast Activity in Patients with Acute and Chronic Diabetic Charcot Neuroarthropathy , 1997, Diabetic Medicine.

[33]  D. Rao,et al.  Bone Loss and Bone Turnover in Diabetes , 1995, Diabetes.

[34]  G. Balian,et al.  Type X Collagen in Fracture Callus and the Effects of Experimental Diabetes , 1994, Clinical orthopaedics and related research.

[35]  M. Bolander,et al.  Defects of early fracture-healing in experimental diabetes. , 1989, The Journal of bone and joint surgery. American volume.

[36]  R. Loder,et al.  The influence of diabetes mellitus on the healing of closed fractures. , 1988, Clinical orthopaedics and related research.

[37]  Dixit Pk,et al.  Retardation of bone fracture healing in experimental diabetes. , 1987 .

[38]  A. Hirschman,et al.  Retardation of fracture healing in experimental diabetes. , 1968, The Journal of surgical research.

[39]  L. McCabe,et al.  Bone loss and increased bone adiposity in spontaneous and pharmacologically induced diabetic mice. , 2007, Endocrinology.

[40]  Louis C Gerstenfeld,et al.  Diabetes causes decreased osteoclastogenesis, reduced bone formation, and enhanced apoptosis of osteoblastic cells in bacteria stimulated bone loss. , 2004, Endocrinology.

[41]  A. Parker,et al.  Expression profiling of metalloproteinases and their inhibitors in cartilage. , 2004, Arthritis and rheumatism.

[42]  T A Einhorn,et al.  Impaired fracture healing in the absence of TNF-alpha signaling: the role of TNF-alpha in endochondral cartilage resorption. , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[43]  D. Graves,et al.  Diabetes interferes with the bone formation by affecting the expression of transcription factors that regulate osteoblast differentiation. , 2003, Endocrinology.

[44]  A. M. Herskind,et al.  Diabetes mellitus and healing of closed fractures. , 1992, Diabete & metabolisme.

[45]  R. A. Ekstrom,et al.  Retardation of bone fracture healing in experimental diabetes. , 1987, The Indian journal of medical research.